Comcast Ventures returned for a $35.1m round for the financial planning service that took place two years after it emerged from stealth.

Founded by University of Washington faculty, Proprio has raised series A funding to commercialise its multi-camera surgical imaging system.

Backed by Intel and HTC as of its launch early last year, Proprio has now raised a total of $30m to commercialise its multi-camera surgical imaging system.

Existing investors Gradient Ventures and Bloomberg Beta returned for a round that took the machine learning software developer's total funding to $27m.

SK China, Xiaomi and Lenovo were among the investors as BYD's electric vehicle chip spinoff added $113m to the $265m it announced last month.

Cullinan Oncology contributed to a series A round that funded the launch of a cancer drug-focused joint venture with PDI Therapeutics.

GV, a corporate venturing subsidiary of internet and technology group Alphabet, has led a $63m series A2 round for Verve Therapeutics, a US-based developer of genomic heart disease drugs.

University of Cambridge stem cell differentiation spinout Bit Bio secured $41.5m from investors including Arch Venture Partners to boost its overall funding to $50m.

The Aalto University and VTT quantum computer spinout has lined up a potential series A round with an initial $16.9m contribution from EIC Accelerator.

Genomic heart disease drug developer Verve Therapeutics secured funding in a round led by GV, which also led its series A last year.